Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials
Titel:
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials
Auteur:
Bernstein, Jonathan A Virchow, J Christian Murphy, Kevin Maspero, Jorge Fernando Jacobs, Joshua Adir, Yochai Humbert, Marc Castro, Mario Marsteller, Douglas A McElhattan, Jennifer Hickey, Lisa Garin, Margaret Vanlandingham, Rebecca Brusselle, Guy